Post Stroke Cognitive Impairment

clinical evaluation of the prevalence and severity of cognitive impairment among patients after ischemic and haemorrhagic stroke admitted to the Neuropsychiatry department

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Cognition - Other

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Observational

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients of both sexes, aged 18- 60 years, with a history of first stroke within 3 months of admission, all types of stroke confirmed by imaging (ischemia, parenchymal haemorrhage, subarachnoid haemorrhage, venous stroke)

Exclusion criteria

Age above 60 years, refusal to participate in the study, pre-existing dementia or significant psychiatric illness, severe aphasia or communication deficits precluding cognitive testing or severe comorbid condition limiting follow-ups, systemic diseases that are known to affect the central nervous system, such as (thyroid dysfunction, chronic infections, or system failure like liver or renal failure), significant sensory impairment (deafness and blindness), history of malignancy and those who have had neurosurgical procedures or severe head trauma at any time before a stroke.

Treatment and study plan

Cognitive assessment: Montreal Cognitive Assessment (MoCA), Cognitive Assessment for Stroke patients, Oxford cognitive screening, Trail Making Test B, Digit Span-Backward, verbal fluency, Clinical Dem

Other

Follow-up: for cognitive and functional reassessment

Primary outcomes

the prevalence of cognitive impairment among patients after ischemic and haemorrhagic stroke admitted to the Neuropsychiatry department

Time frame: baseline

clinical evaluation of the prevalence of cognitive impairment among patients after ischemic and haemorrhagic stroke admitted to the Neuropsychiatry departmen
prevalence estimates of PSCI within the stroke population admitted to a tertiary hospital.

Time frame: baseline

Study contacts

Contact information is provided by the study sponsor or research team.

kamal eldin Mohamed

CONTACT

[email protected]

0201003983057

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Evaluation of Post-Stroke Cognitive Impairment in Patients Attending the Neuropsychiatry Department- Assiut University

Important dates

Study start: 2026
Primary completion: 2027
Study completion: 2027
First posted: Jan 6, 2026
Registry last updated: Jan 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, Not Recruiting